Trials / Terminated
TerminatedNCT02682420
everlinQ endoAVF Post Market Study
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- C. R. Bard · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, multi-center study to evaluate the everlinQ endoAVF System when used to create an endovascular arteriovenous fistula (endoAVF) for patients who require vascular access for hemodialysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | everlinQ endoAVF System |
Timeline
- Start date
- 2016-09-20
- Primary completion
- 2019-08-01
- Completion
- 2019-08-01
- First posted
- 2016-02-15
- Last updated
- 2025-12-11
- Results posted
- 2021-11-17
Locations
11 sites across 3 countries: Canada, Germany, United Kingdom
Source: ClinicalTrials.gov record NCT02682420. Inclusion in this directory is not an endorsement.